Chen CF, Liu J, Wang SS, Yao YF, Yu B, Hu XP. Mycobacterium abscessus infection after facial injection of argireline: A case report. World J Clin Cases 2021; 9(8): 1996-2000 [PMID: 33748252 DOI: 10.12998/wjcc.v9.i8.1996]
Corresponding Author of This Article
Xiao-Ping Hu, PhD, Associate Professor, Department of Dermatology & Venereology, Peking University Shenzhen Hospital, No. 1120 Lianhua Road, Futian District, Shenzhen 518036, Guangdong Province, China. xiaoping7752@sohu.com
Research Domain of This Article
Dermatology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Mar 16, 2021; 9(8): 1996-2000 Published online Mar 16, 2021. doi: 10.12998/wjcc.v9.i8.1996
Mycobacterium abscessus infection after facial injection of argireline: A case report
Chao-Feng Chen, Jie Liu, Shuang-Shuang Wang, Yu-Fang Yao, Bo Yu, Xiao-Ping Hu
Chao-Feng Chen, Jie Liu, Shuang-Shuang Wang, Yu-Fang Yao, Bo Yu, Xiao-Ping Hu, Department of Dermatology & Venereology, Peking University Shenzhen Hospital, Shenzhen 518036, Guangdong Province, China
Author contributions: These authors contributed equally to this work and should be considered as joint first authors. Hu XP reviewed the data and consulted the authors; Chen CF and Liu J wrote the article and extracted the data; Wang SS, Yao YF, and Yu B revised and edited the article.
Supported byThe Scientific Research Project of Peking University Shenzhen Hospital, No. JCYJ2018011 and the San-ming Project of Medicine in Shenzhen, No. SZSM201812059.
Informed consent statement: Informed written consent was obtained from the patient and her parents for the publication of this report and any accompanying images.
Conflict-of-interest statement: No conflict of interest is declared.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xiao-Ping Hu, PhD, Associate Professor, Department of Dermatology & Venereology, Peking University Shenzhen Hospital, No. 1120 Lianhua Road, Futian District, Shenzhen 518036, Guangdong Province, China. xiaoping7752@sohu.com
Received: November 23, 2020 Peer-review started: November 23, 2020 First decision: December 13, 2020 Revised: December 14, 2020 Accepted: January 15, 2021 Article in press: January 15, 2021 Published online: March 16, 2021 Processing time: 101 Days and 19.6 Hours
Abstract
BACKGROUND
The incidence of infection with Mycobacterium abscessus (M. abscessus) has increased in recent years. This increase is partly associated with invasive cosmetic procedures.
CASE SUMMARY
The purpose of this case summary is to increase clinicians' awareness of M. abscessus infection and reduce mycobacterial infection caused by cosmetic procedures. We report the case of a 45-year-old woman who received acetyl hexapeptide-8 (argireline) injections in the forehead and temples, and erythema, nodules, and abscesses appeared at the injection sites after one week. The pus specimens were examined by microbiological culture and confirmed to be positive for M. abscessus. Clarithromycin 500 mg twice daily and moxifloxacin 400 mg once daily were administered for 5 mo and the lesions gradually subsided.
CONCLUSION
We report here for the first time a case of infection with M. abscessus after argireline injection. This condition is easily misdiagnosed as a common bacterial infection. Microbiological examinations are helpful for diagnosis and standardized cosmetic procedures can prevent infection with M. abscessus.
Core Tip: Mycobacterium abscessus (M. abscessus) is a rapidly growing nontubercul-ous mycobacterium that can lead to infections of the lung, lymph node, skin, and soft tissue. The incidence of infection with M. abscessus has increased in recent years. This increase is partly associated with invasive cosmetic procedures. We report here for the first time a case of infection with M. abscessus after argireline injection. The purpose of this case summary is to increase clinicians' awareness of M. abscessus infection and reduce mycobacterial infection caused by cosmetic procedures.
